| Literature DB >> 31772715 |
Baoyu Yang1, Xiuli Lu1, Yang Li1,2, Yuanyuan Li3, Daojun Yu2,4, Weiwen Zhang3, Chaojie Duan3, Kazumi Taguchi4,5, Takahiro Yasui4,5, Kenjiro Kohri4,5, Bing Gao2,3,4.
Abstract
Crystal-cell interactions are a vital step toward kidney stone formation. However, its mechanisms remained unclear. Here, a protein-protein interaction (PPI) network analysis of a kidney stone revealed that the proteins were enriched in a posttranslational protein modification process in the endoplasmic reticulum (ER). The in vitro study showed that the markers of ER stress, including Bip and CHOP, were upregulated, PERK and ATF6 were activated, and XBP-1 mRNA was spliced. An ER stress-specific protein, caspase-12, was activated in the apoptotic cells induced by calcium oxalate monohydrate (COM) crystals. The treatment with tunicamycin, an ER stress inducer, promoted the crystal-cell adhesion assayed by atomic absorption, reduced cell viability assayed by MTT, and downregulated the expression of proteins involved in the crystal formations. The treatment with salubrinal, an ER stress inhibitor, reversed the above effects for both tunicamycin and COM crystals. The aforementioned main observations were supported by in vivo study. These data demonstrated that ER stress was an essentially biological process of crystal-cell interactions. Our findings suggest that blocking ER stress may become a potential approach to preventing a kidney stone.Entities:
Mesh:
Year: 2019 PMID: 31772715 PMCID: PMC6854948 DOI: 10.1155/2019/9307256
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Figure 1Network analysis of a kidney stone. A flowchart of network construction and a GO analysis (a). The primary kidney stone PPI network was constructed from protein sets obtained from PolySearch and a proteomics data by Wright et al. [13], which consisted of 340 nodes connected via 740 edges (b). The backbone kidney stone PPI network was derived from the primary kidney stone PPI network, which consisted of 31 nodes connected via 51 edges (c). Bigger nodes represent genes with more links.
Gene Ontology analysis for the backbone network of a kidney stone.
| Term | Count | % |
| Benjamini | FDR | Genes |
|---|---|---|---|---|---|---|
| GOTERM_BP_DIRECT | ||||||
| GO:0022617~extracellular matrix disassembly | 5 | 16.129 | 8.45 | 0.00493 | 0.012443 | BSG, A2M, MMP9, CDH1, FN1 |
| GO:0006457~protein folding | 6 | 19.3548 | 1.33 | 0.00388 | 0.019533 | HSP90AB1, P4HB, HSP90B1, HSP90AA1, APCS, CALR |
| GO:0050821~protein stabilization | 5 | 16.129 | 8.13 | 0.01573 | 0.119559 | HSP90AB1, HSP90AA1, APOA1, CALR, GAPDH |
| GO:0036500~ATF6-mediated unfolded protein response | 3 | 9.67742 | 1.03 | 0.01495 | 0.151433 | HSP90B1, HSPA5, CALR |
| GO:0006950~response to stress | 4 | 12.9032 | 1.64 | 0.01897 | 0.240659 | HSP90AB1, MAPK1, HSP90B1, HSP90AA1 |
| GO:0006898~receptor-mediated endocytosis | 5 | 16.129 | 1.85 | 0.01786 | 0.271641 | HSP90B1, HSP90AA1, APOA1, CALR, CD14 |
| GO:0034975~protein folding in endoplasmic reticulum | 3 | 9.67742 | 2.22 | 0.01839 | 0.326434 | HSP90B1, HSPA5, CALR |
| GO:1900034~regulation of cellular response to heat | 4 | 12.9032 | 2.88 | 0.02084 | 0.422888 | HSP90AB1, MAPK1, HSP90AA1, YWHAE |
| GOTERM_CC_DIRECT | ||||||
| GO:0070062~extracellular exosome | 24 | 77.4194 | 3.39 | 4.40 | 3.94 | HSP90AB1, P4HB, A2M, BSG, APCS, HSP90AA1, MMP9, YWHAB, CDH1, ITGB2, CALR, YWHAE, PCK1, JUP, MAPK1, HSP90B1, APOA1, EIF4A1, YWHAQ, HSPA5, EGF, GAPDH, CD14, FN1 |
| GO:0042470~melanosome | 8 | 25.8065 | 1.85 | 1.20 | 2.16 | HSP90AB1, P4HB, HSP90B1, BSG, HSP90AA1, YWHAB, HSPA5, YWHAE |
| GO:0005925~focal adhesion | 11 | 35.4839 | 2.87 | 1.24 | 3.34 | JUP, MAPK1, P4HB, HSP90B1, BSG, YWHAB, YWHAQ, CDH1, HSPA5, CALR, YWHAE |
| GO:0031012~extracellular matrix | 10 | 32.2581 | 5.97 | 1.94 | 6.95 | JUP, P4HB, HSP90B1, HSP90AA1, APCS, EIF4A1, HSPA5, CALR, GAPDH, FN1 |
| GO:0071682~endocytic vesicle lumen | 4 | 12.9032 | 2.01 | 5.22 | 0.002338 | HSP90B1, HSP90AA1, APOA1, CALR |
| GO:0005829~cytosol | 18 | 58.0645 | 2.02 | 4.38 | 0.002354 | HSP90AB1, AR, A2M, HSP90AA1, EXOC7, YWHAB, CALR, TAB1, YWHAE, PCK1, JUP, MAPK1, HSP90B1, APOA1, EIF4A1, YWHAQ, HBG2, GAPDH |
| GO:0005576~extracellular region | 13 | 41.9355 | 2.69 | 4.99 | 0.003128 | P4HB, A2M, BMP2, APCS, HSP90AA1, MMP9, CDH1, CALR, HSP90B1, APOA1, EGF, CD14, FN1 |
| GO:0005913~cell-cell adherens junction | 7 | 22.5807 | 1.00 | 1.63 | 0.011684 | HSP90AB1, JUP, BSG, YWHAB, CDH1, HSPA5, YWHAE |
| GO:0016020~membrane | 14 | 45.1613 | 1.18 | 1.70 | 0.013736 | HSP90AB1, HSP90B1, BSG, HSP90AA1, EXOC7, EIF4A1, YWHAB, YWHAQ, CDH1, ITGB2, HSPA5, CALR, GAPDH, YWHAE |
| GO:0072562~blood microparticle | 5 | 16.129 | 7.86 | 0.00102 | 0.091484 | A2M, APOA1, APCS, HBG2, FN1 |
| GO:0034663~endoplasmic reticulum chaperone complex | 3 | 9.67742 | 1.34 | 0.00158 | 0.155484 | P4HB, HSP90B1, HSPA5 |
| GO:0009986~cell surface | 7 | 22.5807 | 2.14 | 0.00232 | 0.249403 | HSP90AB1, BMP2, HSP90AA1, APOA1, ITGB2, HSPA5, CALR |
| GO:0005788~endoplasmic reticulum lumen | 5 | 16.129 | 2.32 | 0.00232 | 0.269618 | P4HB, HSP90B1, APOA1, HSPA5, CALR |
| GOTERM_MF_DIRECT | ||||||
| GO:0005515~protein binding | 27 | 87.0968 | 4.47 | 8.09 | 5.51 | HSP90AB1, A2M, EXOC7, MMP9, ITGB2, CDH1, CALR, APOA1, HSPA5, EGF, GAPDH, FN1, P4HB, AR, BSG, BMP2, CTBP2, HSP90AA1, YWHAB, TAB1, YWHAE, JUP, MAPK1, HSP90B1, EIF4A1, YWHAQ, CD14 |
| GO:0001948~glycoprotein binding | 6 | 19.3548 | 9.67 | 8.75 | 1.19 | HSP90AB1, HSP90AA1, CDH1, ITGB2, HSPA5, CALR |
| GO:0051082~unfolded protein binding | 6 | 19.3548 | 1.32 | 7.96 | 0.001626 | HSP90AB1, HSP90B1, HSP90AA1, APCS, HSPA5, CALR |
| GO:0098641~cadherin binding involved in cell-cell adhesion | 7 | 22.5807 | 1.24 | 5.62 | 0.015318 | HSP90AB1, JUP, BSG, YWHAB, CDH1, HSPA5, YWHAE |
| GO:0019899~enzyme binding | 7 | 22.5807 | 2.62 | 9.50 | 0.032354 | P4HB, AR, A2M, APOA1, YWHAB, HSPA5, YWHAE |
| GO:0023026~MHC class II protein complex binding | 3 | 9.67742 | 3.86 | 0.01158 | 0.47498 | HSP90AB1, HSP90AA1, YWHAE |
| KEGG_PATHWAY | ||||||
| hsa05200: pathways in cancer | 12 | 38.7097 | 1.00 | 1.36 | 1.17 | HSP90AB1, JUP, MAPK1, AR, HSP90B1, BMP2, HSP90AA1, CTBP2, MMP9, CDH1, EGF, FN1 |
| hsa04151: PI3K-Akt signaling pathway | 10 | 32.2581 | 3.66 | 2.49 | 0.004295 | HSP90AB1, MAPK1, HSP90B1, HSP90AA1, YWHAB, YWHAQ, EGF, YWHAE, FN1, PCK1 |
| hsa05215: prostate cancer | 6 | 19.3548 | 1.93 | 8.76 | 0.022701 | HSP90AB1, MAPK1, AR, HSP90B1, HSP90AA1, EGF |
| hsa04114: oocyte meiosis | 6 | 19.3548 | 5.45 | 0.00185 | 0.063994 | MAPK1, AR, YWHAB, YWHAQ, PPP3R2, YWHAE |
| hsa04621: NOD-like receptor signaling pathway | 5 | 16.129 | 5.50 | 0.0015 | 0.064592 | HSP90AB1, MAPK1, HSP90B1, HSP90AA1, TAB1 |
| hsa04390: Hippo signaling pathway | 6 | 19.3548 | 2.55 | 0.00577 | 0.299238 | BMP2, YWHAB, YWHAQ, CDH1, ITGB2, YWHAE |
| hsa04141: protein processing in endoplasmic reticulum | 6 | 19.3548 | 4.30 | 0.00833 | 0.503915 | HSP90AB1, P4HB, HSP90B1, HSP90AA1, HSPA5, CALR |
| hsa05219: bladder cancer | 4 | 12.9032 | 5.14 | 0.0087 | 0.601459 | MAPK1, MMP9, CDH1, EGF |
| hsa04915: estrogen signaling pathway | 5 | 16.129 | 5.40 | 0.00813 | 0.632287 | HSP90AB1, MAPK1, HSP90B1, HSP90AA1, MMP9 |
Figure 2Markers and key sensors of ER stress were activated in HK2 cells under COM crystal exposure. The Bip/GRP78 significantly increased from three to 48 hours (a, c), and the CHOP was increased from 12 to 24 hours, after exposure to COM crystals (a, d). Phospho-PERK (P-PERK) was increased to three hours (a, e). Cleaved ATF6 was increased from three to 48 hours (a, f). XBP-1 was decreased to 12 hours and then increased to 24 hours (a, g). The spliced XBP-1 mRNA was upregulated from three hours to 12 hours (b, h). ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
Figure 3The ER stress-specific caspase was involved in apoptosis induced by COM crystals. Apoptotic cells were detected by the TUNEL and Hoechst assay (a). COM crystal exposure significantly increased apoptotic cell numbers (∗∗∗P < 0.001) compared with the control group (b). The ER stress-specific caspase-12, caspase-3, phospho-JNK (P-JNK), and phospho-P38 (P-P38) expression was all detected in a time-dependent manner using a western blot (c–g). ∗∗∗P < 0.001, ∗P < 0.05.
Figure 4The effect of ER stress on crystal-cell interaction. (a) ER stress promoted crystal-cell adhesion. In the TM+COM group, the HK2 cells were treated with COM crystals for five minutes after exposing TM, an inducer of ER stress, for 24 hours. The COM crystals that adhered to the cells were lysed with 5 ml of 6 M HCl. A quantitative analysis of the COM crystals was conducted, by measuring the concentration using an atomic absorption method. Crystal adhesion in the TM+COM group rose significantly compared with the COM group (∗∗∗P < 0.001), and SAL reversed it (∗∗P < 0.01). SAL also reduced crystal-cell adhesion after exposure to COM crystals (∗P < 0.05). (b) ER stress induced by TM affected the expression of proteins associated with the formation of a kidney stone. Protein expression showed a similar trend between TM exposure and COM exposure. ∗,#P < 0.05, ∗∗,##P < 0.01, and ∗∗∗,###P < 0.001 vs. 0 h. (c) ER stress induced by TM reduced cell viability, and SAL reversed it in vitro. HK2 cells were exposed to 100 μg/ml COM crystals and 1 μg/ml TM for two days, respectively. COM crystals and TM significantly reduced cell viability (∗P < 0.05). HK2 cells were exposed to 100 μg/ml COM crystals and 1 μM SAL+100 μg/ml COM crystals for two days, respectively. SAL significantly increased cell viability compared with the group of COM crystals (∗∗∗P < 0.001). (d) The number of cells was compared to that of the group of COM and the group of COM+SAL for 12, 24, and 48 hours. The number of cells in the COM+SAL group significantly increased at 24 hours (∗P < 0.05). TM represented tunicamycin. SAL represented salubrinal.
Figure 5Marker proteins of ER stress expressed changes in rats treated with 0.75% EG from day zero to eight weeks. Crystals were formed from the 2nd week. The red arrow points to the crystal (a). The Bip/GRP78, CHOP, phospho-PERK (P-PERK), ATF6, caspase-3, and caspase-12 were activated (b). XBP-1 was spliced (c).